C4 Therapeutics, Inc. (CCCC Quick Quote CCCC - Free Report) has been beaten down lately with too much selling pressure. While the stock has lost 21.9% over the past four weeks, there is light at the ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. C4 Therapeutics, Inc. (CCCC) is a stock that can certainly grab the attention of ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is C4 Therapeutics, Inc. (CCCC) one of those stocks right now? A ...

C4 Therapeutics, Inc. (CCCC) shares rallied 13.7% in the last trading session to close at $7.38. This move can be attributable to notable volume with a higher number of shares being traded than in a ...

C4 Therapeutics Inc. Annual cash flow by MarketWatch. View CCCC net cash flow, operating cash flow, operating expenses and cash dividends.

C4 Therapeutics (NASDAQ:CCCC) just reported results for the second quarter of 2024. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings ...

C4 Therapeutics, Inc. (NASDAQ:CCCC) is one of the 10 Best High-Risk Penny Stocks to Buy Right Now. According to CNN’s compilation of price targets, all 8 analysts covering C4 Therapeutics, Inc.

Investors might want to bet on Vodafone Group PLC (VOD), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

C4 Therapeutics, Inc. (CCCC) has been on a downward spiral lately with significant selling pressure. After declining 26.2% over the past four weeks, the stock looks well positioned for a trend ...